P-550 Phase 1–2 dose-ranging trial of TLK286 (TELCYTA) and Cisplatin (C) as first-line treatment in advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S262 ◽  
Author(s):  
V. Papadimitrakopoulou ◽  
M. Edelman ◽  
R. Zinner ◽  
G. Blumenschein ◽  
S. Jones ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Dose Ranging ◽  
First Line Treatment

Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal

2009 ◽  
Vol 10 (11) ◽  
pp. 1031-1032 ◽  
Author(s):  
Panagiota Vrouchou ◽  
Prashanth Kandaswamy ◽  
Elisabeth George ◽  
David Barnett
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document